Tag Archives: Career

Covid 19 coronavirus: Customs fired nine border workers for refusing vaccines | Instant News


Customs confirmed nine border workers had been fired for refusing to be vaccinated against Covid-19. Photo / Alex Burton

LATEST VIRUS
* Bubble problem: Flights from Perth to New Zealand were canceled following positive cases
* NZ MIQ facilities are ‘four times more likely’ to be breached than Australian facilities
* COVID-19-hit India: 400,000 new cases, 18 killed in hospital fires
* Many young people have turned to post-Covid careers
* Jane Clifton: The silence of the government about immigration is deafening

Nine Customs workers have been fired for refusing the Covid-19 vaccine, including four from a provincial port.

Their contracts were terminated after Customs could not find suitable alternative roles for the workers.

It comes as more problems hit Tasman’s overnight travel bubble.

Flights from Western Australia to New Zealand were canceled last night after a security guard at the MIQ Perth facility tested positive for Covid.

Air New Zealand and Singapore Airlines flights due to take off from Perth and land in Auckland this morning were canceled, but there is still uncertainty over flights to Western Australia from New Zealand.

The Air NZ NZ175 flight to Perth this morning had been delayed until 14.30, but staff at the airport were unable to confirm to the Herald if the delay was due to a Perth MIQ worker testing positive. Qantas told the Herald it had no scheduled flights from Western Australia to New Zealand today, and all flights were operating as normal.

The Health Ministry said the next update would be issued at 1pm today.

New Zealand’s Covid-19 Public Health Response (Vaccination) Order went into effect at 11:59 p.m. on Friday, April 30, and requires all workers in managed isolation and quarantine (MIQ) facilities and those working for Government agencies at the border to be vaccinated. .

Deputy chief executive of customs and capabilities Jacinda Funnell confirmed to Stuff that nine employees, including four at the provincial port, had been terminated because they were not vaccinated.

A maritime border worker, who asked not to be named, told Stuff he was grieved at being fired after what he said was a lack of consultation by the agency.

They were not offered redundancy payments because their roles were not canceled, Customs said. The agency maintains communication with workers.

Catherine Stewart, an Auckland employment attorney, reportedly said employers of workers who are required to be vaccinated are likely to “substantively justify the dismissal of unvaccinated employees”.

Under the Covid-19 Public Health Response (Vaccination) Order, they can demonstrate that they cannot legally retain unvaccinated people in that role.

But he said employers also had to follow a strict process.

“This means that they have to consult staff and, if a worker is reluctant to be vaccinated, confirm the reasons and work with them to try to effectively coax them into being vaccinated,” he told Stuff.

“If workers still don’t want to be vaccinated then employers should consider alternatives and try to shift workers to roles that don’t require vaccination, to save workers’ jobs.”

Even though it is the employee’s choice, the consequence of not vaccinating is the loss of their job.

Frontline workers who refuse to be vaccinated can be barred from their role.  Photo / Alex Burton
Frontline workers who refuse to be vaccinated can be barred from their role. Photo / Alex Burton

One of the workers who worked until Friday at the provincial port monitoring international ships to ensure the crew was taking proper Covid precautions told Stuff he never had contact with the crew, and believed there was not enough risk to justify being asked to be vaccinated. .

He will not reveal his reasons for not getting the vaccine.

In a letter sent to him on Friday, Customs said the nature of his position meant it was unlikely to change his role to reduce his exposure to Covid-19.

A meeting was held with women’s law attorney Ashleigh Fechney in Christchurch, where Customs disagreed that they were in fact going through a redundancy process and that there were insufficient health and safety risks to mandate mandatory vaccinations.

In a letter, the agency said that the role was ongoing.

“Given the matters we discussed at the meeting, including the reasons why Customs requires that your position be carried out by a vaccinated person, the Government’s requirement that unvaccinated border workers stop working in that position by May 1, and the absence of any transfer appropriate opportunity, we inform you that Customs has decided to terminate your work as proposed, “the letter said.

More than 95 percent of Customs staff had their first dose and more than 85 percent of the second, Funnell said.

Perth-NZ flights must ‘stop immediately’

The Ministry of Health (MOH) announced shortly after 10pm last night that officials had “conducted a rapid public health assessment for New Zealand” and decided flights from Western Australia to New Zealand should be temporarily suspended.

The announcement comes after a security guard working in a hotel quarantine in Perth tested positive for Covid-19 yesterday. Two of the seven people who shared the man’s house also had positive results.

“Ministry officials have conducted a rapid public health assessment for New Zealand, and have determined that direct scheduled flights from Western Australia to New Zealand should be suspended immediately while further assessments are carried out, including further assessments and information from Australian health officials,” said the statement. Department of health.

Western Australian health officials have identified a number of locations of interest listed on their website.

Anyone who has left Perth in the last four days and arrived in New Zealand should check out these exciting locations.

New arrivals to New Zealand who are already in this attractive location should self-isolate immediately and contact Healthline in the morning for further advice.

Further information will be released on Sunday, the ministry said.

Covid

Western Australian Prime Minister Mark McGowan said in a press conference yesterday that the country would not lock in “at this time”.

“But maybe this could change tomorrow or the day after,” he said.

The security guard, a man in his 20s living in Nollamara, has received the first dose of the coronavirus vaccine, McGowan said.

He has worked at the Pan Pacific Hotel on April 24, 25 and 26, during which time new arrivals are allowed into the hotel.

He works on the same floor as two hotel quarantine occupants who have tested positive for Covid-19.

“The CCTV vision is being reviewed. However, there is no clear explanation at this point of how the security guards got infected,” said McGowan.

“There is a possibility that transmission could occur when international arrivals are received at the hotel quarantine and possibly transferred to their rooms.

“This is being investigated further.”

The man’s household included two guests from Canberra, McGowan said.

He said the man visited several locations in the community while likely having been contagious, including the Northlands shopping center, Coles, a cafe and a mosque.

Locations of current interest include:

• Al Taqwa Mosque in Mirrabooka on April 30 between 13.15 and 14.00.
• Coles at Prime West Northlands Shopping Center in Balcutta on April 29 between 4:30 PM and 5:15 PM.
• Agha Juice Café in Joondanna on April 28 between 6.50pm and 8pm.
• Smokemart at Prime West Northlands Shopping Center in Balcutta on April 28 between 13.30 and 15:15.
• Northlands Fresh at Prime West Northlands Shopping Center in Balcutta on April 28 between 13.30 and 15:15.
• Sown in Stirling on April 28 between 1.30 and 2.30.
• Swan Taxi Victoria Park on April 27 between 15: 50-14: 45.

.



image source

CHAPTER 2 LOOKING FOR A PR, FASHION MANAGER | Instant News


.



image source

RK Communications Seeking Fashion Internships In Los Angeles | Instant News


.



image source

NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer | Instant News


STANS, Switzerland, April 5, 2021 / PRNewswire / – NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) (“NLS” or “Company”), a Swiss clinical stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare central diseases and complex nervous system disorders, announced the appointment of Silvia Panigone, Ph. .D., EMBA as Chief Operating Officer. Dr. Panigone brings to NLS more than 25 years of leadership experience in the health care industry, founded and operates ADYA Consulting, a boutique advisory firm that provides strategic counseling, access to capital, and M&A consulting services to companies in the life science sector, and serves in operational and managerials in international pharmaceutical companies and clinical research organizations.

“Silvia’s outstanding experience in product development and strategic leadership in the life science industry is a perfect fit for NLS as we pursue development of Quilience® to treat narcolepsy, and define our strategy for business development and advancement of our drug pathway,” said Alex Zwyer, Executive Director of NLS Pharmaceutics. “Its proven ability to guide emerging biotech and pharmaceutical companies from the early stages of development through a period of significant growth will be critical as we seek to drive corporate initiatives and build value within the Company. All of us at NLS give a warm welcome to Silvia. “

“I am delighted to join the NLS team and oversee the main operational activities of the Company so that we can provide patients with new treatments for rare and complex CNS disorders,” said Dr. Panigone. “NLS is focused on developing therapies intended to meet unmet medical needs, and our flagship product, Quilience, ® has the potential to be the first-line treatment for narcolepsy targeting the orexin-2 receptor, the root cause of the disorder. Given the importance of this candidate product, a top priority we are getting IND approval in the US and getting Quilience to the clinic as fast as possible. “

Prior to joining the NLS, Dr. Panigone is the managing director of ADYA Consulting Sagl, a Swiss investment boutique in the life science sector that operates globally and supports companies in corporate strategy and fundraising. He has also acted as temporary management in about one-third of ADYA’s biotech and pharmaceutical clients, and has held several Board positions in private companies, helping some to realize M&A solutions. Dr. Panigone combines a deep understanding of corporate finance as well as the drug development process and execution. Prior to ADYA, he was the former President Director Europe at I-Bankers Direct LLC, an equity funding web platform, as well as Advisor to I-Bankers Securities, Inc., a US investment banking group with more than 140 main offerings and co-managed offerings. He previously served as Fund Manager at BSI Healthcapital, a life science-focused venture capital firm, and Head of Venture Investments in the Merchant division of the Swiss-based bank, EFG International. Dr. R&D Experience Panigone’s broad range includes serving in operational and managerial positions at international level in pharmaceutical and CRO companies. At Bracco SpA, he leads international programs at both the preclinical and clinical stages with the regulatory team, intellectual property, CMC, preclinical and clinical internal experts, external providers, and KOL overseeing the development program as a Sponsor. He is also Global Project Manager at Quintiles Innovex Ltd., a leading global CRO, where he is responsible for managing a large clinical program conducted in the USA, Europe and Asia. Previously, Dr. Panigone serves as Senior Director at XoVenture, a global network of Life Science entrepreneurs and executives, Start-Up Coach for the Swiss government (Innosuisse), University Board Member Milan, and is a member of the European Narcolepsy Network (EUNN). He obtained a degree in Molecular Biology from the University of Milan, Ph.D. in Molecular Oncology at the National Cancer Institute and the Open University, London, and the Executive MBA from the Bocconi SDA School of Management, Milan.

Aabout NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd. is a Swiss-based clinical stage biopharmaceutical company led by an experienced management team with a track record of developing and reusing candidate products to treat rare and complex central nervous system disorders. The Company’s main product candidate, Quilience® is a controlled release formulation of mazindol (mazindol CR) (mazindol CR), and is being developed for the treatment of narcolepsy. Mazindol is a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, which has been used for many years to treat patients diagnosed with narcolepsy in a compassionate use program. The NLS completed a phase 2 study in the US evaluating mazindol CR in adult subjects with ADHD. This study met all primary and secondary end points and was well tolerated. Quilience has received the Orphan Drug Designation both in the US and in Europe for the treatment of narcolepsy.

Safe Harbor Statement

This press release contains the express or implied forward-looking statements pursuant to US Federal securities laws. For example, the NLS uses forward-looking statements when discussing Quilience® which could potentially be the first treatment for narcolepsy targeting the orexin-2 receptor, the root cause of the disorder, as well as when discussing its strategy and pipeline. , initiatives and building values, and potential benefits and approvals from Quilience®. These forward-looking statements and their implications are based on the current expectations of NLS management only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; The NLS may experience delays or bottlenecks in its launch and / or successful completion of its clinical trials; NLS products may not be approved by regulatory bodies, NLS technology may not be validated due to further advances and its methods may not be accepted by the scientific community; NLS may not be able to retain or attract key employees whose knowledge is essential to product development; Unexpected scientific difficulties may develop with the NLS process; The NLS product may become more expensive than anticipated; laboratory results may not translate to equally good results in real clinical settings; the results of preclinical studies may not correlate with the results of clinical trials in humans; The NLS patent may not be enough; NLS products can harm recipients; a change in the law could have a devastating effect on the NLS; inability to develop and introduce new technologies, products and applications in a timely manner; loss of market share and pressure on prices due to competition, which could cause NLS’s actual results or performance to differ materially from those intended in those forward-looking statements. Unless required by law, NLS has no obligation to publish any revisions to this forward-looking statement to reflect events or circumstances after the date of this agreement or to reflect unforeseen events. More detailed information about the risks and uncertainties affecting NLS is provided under the heading “Risk Factors” in the final prospectus of NLS, dated January 28, 2021, filed with the SEC, which is available on the SEC website, www.sec.gov.

Company Contact
Alex Zwyer, CEO: +41 41 618 80 00

Investor Relations Contact
David Moscowitz: +1 202-280-0888

www.nlspharma.com

Cision View original content for multimedia downloads:http://www.prnewswire.com/news-releases/nls-pharmaceutics-appoints-silvia-panigone-phd-as-chief-operating-officer-301261618.html

SOURCE NLS Pharmaceutics Ltd.

.



image source

Australian Sex Scandal Signs Political Culture Is More Toxic than Washington’s | Instant News


Photographer: Mark Graham / Bloomberg

As a Frank Lloyd Wright protégé, he won a global contest for designing Australia’s national capital, the hotbed of evil didn’t seem like what he had imagined. A century since its inception, Canberra has been the byword for ugliness and grim political swamp. It’s a far cry from the geometrically perfect hillside town to be built by Chicago architect Walter Burley Griffin.

At first glance, it is hard to see how the decision to place the Australian capital on the deserted sheep-grazing farm between Sydney and Melbourne has something to do with a series of roaring sex scandals. Prime Minister Scott Morrison’s government. Yet the city’s remote and humble beginnings meant that, historically, few important figures had roots in the areas in which they lived and worked. Canberra is thus a bubble, detached from morals and norms of behavior. This explains, in part, how its poisonous culture took root.

I grew up in Canberra and often defend it against criticism from right-wing talk radio and editorials, which describe it as a remote city full of pampered bureaucrats. That view dispels the hard work of many career civil servants, who toil behind the scenes for relatively modest salaries my parents were among them.

In recent times, however, Canberra has been difficult to defend. Hardly a day goes by without fresh accusations of immoral behavior. Last week, the minister of defense was removed from office after mishandling allegations that a staff member was raped in his parliamentary office. The former Attorney General sued Australian Broadcasting Corp. state-funded libel after reports accusing him of raping a woman in the 1980s, something he strongly denies. He has been transferred to another post. Ten Network recently broadcast allegations that a group of male staff members shared indecent images and videos for two years, including a photo of one of them masturbating on the table of a female lawmaker. The position of the Morrison administration, which clings to thin support in parliament, has been hit. Meanwhile, the prime minister said that unacceptable and that he was disgusted by revelation.

He should be. But I am skeptical he was very surprised. The type of behavior that occurs is endemic to Canberra’s inner circle. That’s especially true of the Houses of Parliament, which has been the ground zero for scandals. Not only do MPs and aides have offices there, but cabinet ministers – even the prime minister – govern from his chambers. That’s where the major media outlets base their coverage. It ignites a hot home atmosphere filled by late nights, multiple environmental water holes and big personal ambitions. Many of the staff are aspiring to be the legislator himself or the office eye is still higher.

A Washington insider may be grinning at how familiar this all sounds. I worked there for a decade and realized it had a lot of the same ingredients. But DC is much more decentralized than Canberra. Cabinet members work from their departmental building. News organizations have headquarters scattered throughout the city. Washington is older and the capital area has about six million people, many of whom were involved in events in other parts of the country. Canberra has nearly 400,000 inhabitants, some of whom live outside the city limits. Washington can be parochial, but compared to Canberra it is worldly.

You may be tempted to argue that the separation of cities from regional politics – as well as the competitive demands of business, finance, labor and agriculture – is an advantage. In practice, however, this has resulted in a detachment from economic reality. It is also very difficult to fire career civil servants, and only voters can send members of parliament. Later, significant parts of Canberra were occupied by a group of isolated temporary people, who worked nearby all day, day and night.

What remains is the huge gap between those in the upper echelons of government and the worker bees that make it function. The army civil servants and military officers occupying the Canberra suburbs were angry. Many are just trying to live and raise a family. Most Canberrans will be happy to spend their time discussing the Raiders, the local rugby league team, or the wildfires that are injuring the hamlet on the south coast of New South Wales, where many spend their holidays.

From time to time, people ask me where I am from in Australia. Usually I get a certain point when I reply, and feel the need to immediately add that I haven’t lived there in decades. This response speaks volumes about Canberra’s low awards at relatively good times. Now, it must be worse.

When I was a child, Lake Burley Griffin, an artificial lake named after its architect, was filled with European goldfish. Fairy tales, perhaps apocryphal, abound about stick-picking dogs that venture into the waters only to be chased by these terrifying creatures. That Canberra Fishing Club hosts an annual “Carp Out” day where residents crowd the lakeside to lure pests. Although these picturesque waters, where many federal buildings congregate, look pristine from afar, locals know very well that the infestation lurks just beneath the surface.

The same can be said of the surrounding cities.

This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.

To contact the author of this story:
Daniel Moss in [email protected]

To contact the editor in charge of this story:
Rachel Rosenthal in [email protected]

.



image source